Spots Global Cancer Trial Database for VXM01 Phase I Study in Patients With Metastatic Colorectal Cancer With Liver Metastasis
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: VXM01 Phase I Study in Patients With Metastatic Colorectal Cancer With Liver Metastasis
Official Title: VXM01 Phase I Study in Patients With Metastatic Colorectal Cancer With Liver Metastasis Under Second or Third Line Therapy to Examine Safety, Efficacy, and Immune Biomarkers After Treatment With VXM01
Study ID: NCT02718430
Conditions
Interventions
Study Description
Brief Summary: Phase I study in patients with metastatic colorectal cancer with liver metastasis under second or third line therapy to examine safety, efficacy, and immune biomarkers after treatment with VXM01
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
National Center of Tumor Diseases, Heidelberg, , Germany
Contact Details
Name: Carsten Gruellich, MD
Affiliation: National Center of Tumor Diseases Heidelberg
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
